Legence Corp.·4

Mar 18, 5:46 PM ET

Sprau Jeffrey 4

Research Summary

AI-generated summary

Updated

Legence (LGN) CEO Jeffrey Sprau Receives Award

What Happened
Jeffrey Sprau, CEO of Legence Corp. (LGN), received equity awards on March 16, 2026: 34,167 restricted stock units (RSUs) and 63,177 derivative option-type awards, for a total of 97,344 units. Both awards were granted at an exercise/grant price of $0.00 (typical for time-based awards) and thus show $0 cash paid at grant. These are awards (code A) rather than purchases or sales.

Key Details

  • Transaction date: 2026-03-16; filing date: 2026-03-18 (timely Form 4 filing).
  • Grant amounts: 34,167 RSUs (F1) and 63,177 derivative awards (F2) — total 97,344 units. Reported price: $0.00.
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Footnotes: F1 — each RSU converts to one share at vesting; RSUs vest in three substantially equal installments on each of the first, second and third anniversaries, subject to continued employment. F2 — the derivative awards are options that vest in three substantially equal installments on the first three anniversaries and expire ten years from grant.
  • No 10b5-1 plan, tax-withholding sale, or immediate sale noted in this filing.

Context
These are standard time‑based compensation awards for an executive and do not represent an open-market purchase or sale. RSUs convert to actual shares only as they vest; the option-type awards are rights to acquire shares subject to vesting and future exercise. Because vesting is spread over three years, these awards align with retention/incentive purposes rather than immediate insider trading signals.